KCT0009312
Not yet recruiting
未知
Therapeutic Effects of Autologous Adipose Tissue-Derived Stromal Vascular Fraction (ADSVF) Implantation for Non-traumatic Osteonecrosis of the Femoral Head: A Double-Blind Randomized Clinical Study with or without ADSVF.
Hyundae Hospital0 sites40 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hyundae Hospital
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects with non\-traumatic femoral head avascular necrosis who consent to this study
- •\- Subjects who have not received other treatments such as core decompression and multiple trepanation for avascular necrosis of the femoral head in the relevant area
- •\- Before the femoral head collapses or when the depth of collapse is less than 2 mm
- •\- Subjects with more than 30% necrosis of the femoral head
Exclusion Criteria
- •\- Subjects with a depth of femoral head collapse of 2 mm or more
- •\- Subjects with more than 30% necrosis of the femoral head
- •\- Subjects who have received treatment of core decompression and multiple trepanation for avascular necrosis of the femoral head in the relevant area
- •\- Subjects taking osteoporosis treatments such as bisphosphonates or parathyroid hormones
- •\- Subjects who are taking immunosuppressants or cytotoxic agents or who need to take them during the test period
- •\- Subjects who must continuously take corticosteroids for treatment purposes
- •\- Subjects who are unable to undergo MRI (magnetic resonance imaging) due to artificial pacemakers, metallic hip joints, prosthetics, etc.
- •\- Subjects who are pregnant or breastfeeding
- •\- Subjects currently suffering from infectious diseases including HIV and hepatitis
- •\- Subjects with serious diseases that may affect this clinical trial: cardiovascular disease, tumor, kidney disease, endocrine disease such as decreased bone metabolism, increased bone metabolism and thyroid disease, autoimmune disease, etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Safty and efficacy of autologuous adipose tissue derived mesenchymal stem cell infusion therapy on liver cirrhosisliver cirrhosisJPRN-UMIN000036136Kyushu university2
Completed
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of OsteoarthritisDegenerative ArthritisKnee OsteoarthritisNCT03990805R-Bio260
Active, not recruiting
Phase 1
Adipose Cell Derived Regenerative Endothelial and Angiogenic MedicinePatients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CLI after revascularization, or with severe cardiac, respiratory or renal disease who are at increased risk of complication from surgery or anesthesia, or with moderately severe or severe heart failure, severe or very severe Chronic Obstructive Pulmonary disease or severe renal disease.Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2018-000967-10-FRniversity Hospital Toulouse43
Completed
Phase 1
Regenerative medicineJPRN-jRCTb050190127Takeda Jun6
Not yet recruiting
Not Applicable
Intra-articular treatment effect of autologous adipose-derived stem cell in patients with arthritisDiseases of the musculoskeletal system and connective tissueKCT0008423Inha University Hospital36